Do you want to link to this Amgen Site outside the UK and leave amgeninflammation.co.uk?
YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.
B cells, also known as B lymphocytes, are part of the humoral immunity component of the adaptive immune system.1 Antibodies, collectively known as immunoglobulins, are exclusively produced by B cells and all antibodies made by an individual B cell possess the same antigen-binding site. During the development of B cells within the bone marrow, antibody molecules are inserted into the plasma membrane, which serve as antigen receptors. Binding of antigens to these receptors in the peripheral lymphoid organs causes B-cell activation and further differentiation into either memory cells or antibody-secreting effector cells.2
Distinct cell surface proteins, including CD40, CD19, and B-cell receptor, are expressed throughout different stages of B-cell development and maturation and are used to identify subsets of B cells, including plasma cells and memory B cells. Upon activation, B cells can differentiate into plasma cells that secrete antibodies, present antigens, and secrete cytokines (IFN-γ, IL-6, and IL-10) that regulate the immune response.1,3 Regulation of normal B-cell activation and longevity is maintained through a delicate balance between the activating and inhibitory processes. Disruption or disturbance of this balance can predispose towards pathogenic autoantibody production and autoimmunity.1
Abnormal B-cell recognition of self-antigen followed by the production of autoantibodies may cause autoimmune diseases. Additionally, B cells also play important roles in modulating inflammation.1,3
CD: cluster of differentiation; IFN-γ: interferon gamma; IL: interleukin.
Adverse events should be reported. Reporting forms and information can be found for the UK at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store, or for Ireland at https://www.hpra.ie/homepage/about-us/report-an-issue. Adverse events and product complaints should also be reported to Amgen Limited on +44 (0)1223 436441 (UK and Northern Ireland) or Freephone 1800 535 160 (Ireland)